<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font20">and </span>
   <span class="font16">The </span>
   <span class="font14">for </span>
   <span class="font13">were </span>
   <span class="font13">was </span>
   <span class="font13">with </span>
   <span class="font13">compounds </span>
   <span class="font13">FIPV </span>
   <span class="font12">al., </span>
   <span class="font12">CLpro </span>
   <span class="font11">that </span>
   <span class="font11">using </span>
   <span class="font11">antiviral </span>
   <span class="font11">cells </span>
   <span class="font11">NSC </span>
   <span class="font11">compound </span>
   <span class="font11">from </span>
   <span class="font11">protease </span>
   <span class="font11">{background </span>
   <span class="font11">viral </span>
   <span class="font11">NSC, </span>
   <span class="font11">which </span>
   <span class="font11">virus </span>
   <span class="font10">against </span>
   <span class="font10">margin </span>
   <span class="font10">each </span>
   <span class="font10">three </span>
   <span class="font10">values </span>
   <span class="font10">{border-style </span>
   <span class="font10">activity </span>
   <span class="font10">candidate </span>
   <span class="font10">px;} </span>
   <span class="font10">showed </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">are </span>
   <span class="font10">concentrations </span>
   <span class="font10">drug </span>
   <span class="font10">this </span>
   <span class="font10">used </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">activities </span>
   <span class="font10">binding </span>
   <span class="font10">could </span>
   <span class="font10">docking </span>
   <span class="font10">feline </span>
   <span class="font10">CRFK </span>
   <span class="font10">been </span>
   <span class="font10">cell </span>
   <span class="font10">have </span>
   <span class="font10">its </span>
   <span class="font10">N/A </span>
   <span class="font10">incubated </span>
   <span class="font10">natural </span>
   <span class="font10">than </span>
   <span class="font10">active </span>
   <span class="font10">assay </span>
   <span class="font10">entry </span>
   <span class="font10">infectious </span>
   <span class="font10">inhibition </span>
   <span class="font10">inhibitor </span>
   <span class="font10">into </span>
   <span class="font10">CID, </span>
   <span class="font10">acid </span>
   <span class="font10">site </span>
   <span class="font10">their </span>
   <span class="font10">μM, </span>
   <span class="font10">also </span>
   <span class="font10">analysis </span>
   <span class="font10">containing </span>
   <span class="font10">coronavirus </span>
   <span class="font10">inhibitors </span>
   <span class="font10">interactions </span>
   <span class="font10">molecular </span>
   <span class="font10">other </span>
   <span class="font10">peritonitis </span>
   <span class="font10">program </span>
   <span class="font10">substrate </span>
   <span class="font10">then </span>
   <span class="font10">CID </span>
   <span class="font10">CLpro. </span>
   <span class="font10">Chem. </span>
   <span class="font10">However, </span>
   <span class="font10">all </span>
   <span class="font10">based </span>
   <span class="font10">different </span>
   <span class="font10">has </span>
   <span class="font10">infected </span>
   <span class="font10">infection </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibitory </span>
   <span class="font10">observed </span>
   <span class="font10">results </span>
   <span class="font10">screening </span>
   <span class="font10">Med. </span>
   <span class="font10">Multimedia </span>
   <span class="font10">RNA </span>
   <span class="font10">Table </span>
   <span class="font10">cell-based </span>
   <span class="font10">component </span>
   <span class="font10">determine </span>
   <span class="font10">further </span>
   <span class="font10">kinetic </span>
   <span class="font10">molecules </span>
   <span class="font10">not </span>
   <span class="font10">pocket </span>
   <span class="font10">post-viral </span>
   <span class="font10">px; </span>
   <span class="font10">selected </span>
   <span class="font10">study, </span>
   <span class="font10">tested </span>
   <span class="font10">within </span>
   <span class="font10">{font-family </span>
   <span class="font10">IPMA </span>
   <span class="font10">USA). </span>
   <span class="font10">activity. </span>
   <span class="font10">available </span>
   <span class="font10">catalytic </span>
   <span class="font10">cleavage </span>
   <span class="font10">concentration </span>
   <span class="font10">drugs </span>
   <span class="font10">entry, </span>
   <span class="font10">evaluated </span>
   <span class="font10">font-size </span>
   <span class="font10">hydrogen </span>
   <span class="font10">lopinavir </span>
   <span class="font10">our </span>
   <span class="font10">parameters </span>
   <span class="font10">properties </span>
   <span class="font10">reaction </span>
   <span class="font10">ribavirin </span>
   <span class="font10">set </span>
   <span class="font10">small </span>
   <span class="font10">treatment </span>
   <span class="font10">two </span>
   <span class="font10">version </span>
   <span class="font10">(Fig. </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Carlsbad, </span>
   <span class="font10">Fig. </span>
   <span class="font10">This </span>
   <span class="font10">assays. </span>
   <span class="font10">best </span>
   <span class="font10">between </span>
   <span class="font10">carried </span>
   <span class="font10">contains </span>
   <span class="font10">data </span>
   <span class="font10">derivatives </span>
   <span class="font10">described </span>
   <span class="font10">double; </span>
   <span class="font10">during </span>
   <span class="font10">effect </span>
   <span class="font10">following </span>
   <span class="font10">genome </span>
   <span class="font10">host </span>
   <span class="font10">including </span>
   <span class="font10">inhibited </span>
   <span class="font10">isolated </span>
   <span class="font10">lower </span>
   <span class="font10">out </span>
   <span class="font10">performed </span>
   <span class="font10">plate </span>
   <span class="font10">potential </span>
   <span class="font10">protein </span>
   <span class="font10">qPCR </span>
   <span class="font10">replication </span>
   <span class="font10">residues </span>
   <span class="font10">respectively. </span>
   <span class="font10">structure </span>
   <span class="font10">study </span>
   <span class="font10">value </span>
   <span class="font10">(Pedersen, </span>
   <span class="font10">CLpro, </span>
   <span class="font10">Cys </span>
   <span class="font10">Elsevier </span>
   <span class="font10">FXa </span>
   <span class="font10">Kim </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">Therefore, </span>
   <span class="font10">USA) </span>
   <span class="font10">action </span>
   <span class="font10">after </span>
   <span class="font10">analysis. </span>
   <span class="font10">any </span>
   <span class="font10">approach </span>
   <span class="font10">assay. </span>
   <span class="font10">assays </span>
   <span class="font10">before </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">can </span>
   <span class="font10">compounds, </span>
   <span class="font10">compounds. </span>
   <span class="font10">conditions </span>
   <span class="font10">control, </span>
   <span class="font10">determined </span>
   <span class="font10">enzyme </span>
   <span class="font10">fluorogenic </span>
   <span class="font10">higher </span>
   <span class="font10">initial </span>
   <span class="font10">less </span>
   <span class="font10">might </span>
   <span class="font10">new </span>
   <span class="font10">novel </span>
   <span class="font10">panel </span>
   <span class="font10">presented </span>
   <span class="font10">previously </span>
   <span class="font10">prophylactic </span>
   <span class="font10">purification </span>
   <span class="font10">reduce </span>
   <span class="font10">resource </span>
   <span class="font10">scoring </span>
   <span class="font10">should </span>
   <span class="font10">software </span>
   <span class="font10">solid; </span>
   <span class="font10">structural </span>
   <span class="font10">subsequently </span>
   <span class="font10">targeting </span>
   <span class="font10">these </span>
   <span class="font10">virtual </span>
   <span class="font10">without </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Kuo </span>
   <span class="font10">(NSC), </span>
   <span class="font10">(Supplementary </span>
   <span class="font10">(Tokyo) </span>
   <span class="font10">-well </span>
   <span class="font10">Antibiot. </span>
   <span class="font10">C-like </span>
   <span class="font10">COVID- </span>
   <span class="font10">CoV </span>
   <span class="font10">FIP </span>
   <span class="font10">FIPV, </span>
   <span class="font10">FIPV-infected </span>
   <span class="font10">Feline </span>
   <span class="font10">LINK </span>
   <span class="font10">Lane </span>
   <span class="font10">MTS </span>
   <span class="font10">Ni-NTA </span>
   <span class="font10">ORFa </span>
   <span class="font10">Res. </span>
   <span class="font10">SARS </span>
   <span class="font10">Supplementary </span>
   <span class="font10">These </span>
   <span class="font10">USA), </span>
   <span class="font10">according </span>
   <span class="font10">added </span>
   <span class="font10">adding </span>
   <span class="font10">amplification </span>
   <span class="font10">better </span>
   <span class="font10">biosynthetic </span>
   <span class="font10">bold </span>
   <span class="font10">centre </span>
   <span class="font10">chemical </span>
   <span class="font10">clinical </span>
   <span class="font10">combination </span>
   <span class="font10">compared </span>
   <span class="font10">courier; </span>
   <span class="font10">culture </span>
   <span class="font10">cysteine </span>
   <span class="font10">cytotoxicity </span>
   <span class="font10">demonstrated </span>
   <span class="font10">drug-like </span>
   <span class="font10">effective </span>
   <span class="font10">em; </span>
   <span class="font10">first </span>
   <span class="font10">fluvirucin </span>
   <span class="font10">function </span>
   <span class="font10">functional </span>
   <span class="font10">gene </span>
   <span class="font10">generated </span>
   <span class="font10">grid </span>
   <span class="font10">group </span>
   <span class="font10">groups </span>
   <span class="font10">hepatitis </span>
   <span class="font10">high </span>
   <span class="font10">human </span>
   <span class="font10">hydrophobic </span>
   <span class="font10">included </span>
   <span class="font10">indicated </span>
   <span class="font10">influenza </span>
   <span class="font10">inoculated </span>
   <span class="font10">interaction </span>
   <span class="font10">kcat </span>
   <span class="font10">known </span>
   <span class="font10">lopinavir, </span>
   <span class="font10">may </span>
   <span class="font10">modification </span>
   <span class="font10">non-covalent </span>
   <span class="font10">numbers </span>
   <span class="font10">positive </span>
   <span class="font10">pre-viral </span>
   <span class="font10">properties, </span>
   <span class="font10">protease, </span>
   <span class="font10">pt;} </span>
   <span class="font10">recombinant </span>
   <span class="font10">reduction </span>
   <span class="font10">reported </span>
   <span class="font10">reverse </span>
   <span class="font10">seven </span>
   <span class="font10">show </span>
   <span class="font10">shown </span>
   <span class="font10">similar </span>
   <span class="font10">solution </span>
   <span class="font10">stictic </span>
   <span class="font10">structures </span>
   <span class="font10">such </span>
   <span class="font10">tag-free </span>
   <span class="font10">target </span>
   <span class="font10">utilized </span>
   <span class="font10">μM. </span>
  </p>
 </body>
</html>
